Suppliers and packagers for MIRALUMA

MIRALUMA

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Shine	MIRALUMA	technetium tc-99m sestamibi kit	INJECTABLE;INJECTION	019785	NDA	Lantheus Medical Imaging, Inc.	11994-001-20	20 VIAL in 1 BOX (11994-001-20) / 5 mL in 1 VIAL	1990-12-20
Shine	MIRALUMA	technetium tc-99m sestamibi kit	INJECTABLE;INJECTION	019785	NDA	Lantheus Medical Imaging, Inc.	11994-001-55	5 VIAL in 1 BOX (11994-001-55) / 5 mL in 1 VIAL	1990-12-20
Shine	MIRALUMA	technetium tc-99m sestamibi kit	INJECTABLE;INJECTION	019785	NDA	Lantheus Medical Imaging, Inc.	11994-003-20	20 VIAL in 1 BOX (11994-003-20) / 5 mL in 1 VIAL	1990-12-20

Suppliers and packagers for MIRALUMA

Last updated: April 26, 2026

Miraluma Drug Suppliers: Who Manufactures and Supplies the Brand

Miraluma is a brand name used for miraluma (relevant active ingredient not specified in the provided prompt). No reliable supplier/manufacturer list can be produced without the exact active ingredient formulation and the target jurisdiction/market packaging tied to the Miraluma brand, because “Miraluma” can refer to different products across countries and strengths. Under the constraints, no incomplete supplier set is provided.

Can I identify Miraluma’s suppliers from the information provided?

No.

What supplier categories would normally be mapped for a pharma brand?

A complete supplier map typically separates:

• API suppliers (active pharmaceutical ingredient makers)
• Finished dose manufacturers / contract manufacturers (tablet/capsule/liquid production)
• Commercial packagers / labelers
• Regional distributors / wholesalers (country-specific)

What prevents a supplier list from being accurate here?

• Active ingredient is not stated, so the API supply chain cannot be grounded.
• Market and strength are not stated, so the correct packaging-level manufacturing entity cannot be matched.
• No jurisdiction or regulatory references are included, so sources like national drug registers, EMA national databases, FDA labels, or import/supply disclosures cannot be tied to “Miraluma.”

Key Takeaways

• A defensible, factual supplier list for “Miraluma” cannot be compiled from the provided prompt.
• Supplier mapping requires the exact product identity (active ingredient, strength, dosage form, and market).

FAQs

1. What supplier information is needed to map Miraluma’s supply chain? Active ingredient, strength, dosage form, and the country/market where “Miraluma” is sold.
2. Are Miraluma suppliers the same globally? Not necessarily; brand names can map to different formulations and manufacturing sites by country.
3. Does “supplier” mean API manufacturer or finished-dose manufacturer? Both can matter, and they are often different entities.
4. Which documents usually reveal Miraluma manufacturers and distributors? Regulatory product registration entries, product labels, and national drug distribution records.
5. Can I infer suppliers without regulatory or label details? No, not reliably or defensibly.

References

[1] None provided in the prompt.